MiMedx (NASDAQ: MDXG) CCO has 6,762 shares withheld for tax

Rhea-AI Filing Summary

MIMEDX GROUP, INC. Chief Commercial Officer Kimberly Maersk-Moller reported a routine tax-related share disposition. On March 13, 2026, 6,762 shares of common stock were withheld at $4.38 per share to cover tax obligations on vesting of restricted stock.

These shares were withheld by the company rather than sold in the open market. After this transaction, Maersk-Moller directly owned 329,450 shares of MiMedx common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Maersk-Moller Kimberly

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	6,762	$4.38	$30K

Holdings After Transaction: Common Stock — 329,450 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maersk-Moller Kimberly

(Last) (First) (Middle)

1775 WEST OAK COMMONS COURT

(Street)

MARIETTA GA 30062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		F		6,762(1)	D	$4.38	329,450	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld by the Company to satisfy tax withholding requirements on vesting of restricted stock.

Remarks:

	/s/ William F. Hulse, as attorney-in-fact for Kimberly Maersk-Moller	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MiMedx (MDXG) Chief Commercial Officer report in this Form 4?

MiMedx Chief Commercial Officer Kimberly Maersk-Moller reported a tax-related share disposition. The company withheld 6,762 common shares to cover tax obligations triggered by restricted stock vesting, a routine administrative transaction rather than an open-market trade.

How many MiMedx (MDXG) shares were withheld for taxes in this filing?

A total of 6,762 MiMedx common shares were withheld for taxes. The withholding occurred at a price of $4.38 per share, tied to the vesting of restricted stock granted as compensation to the Chief Commercial Officer.

Was the MiMedx (MDXG) Form 4 transaction an open-market sale?

The Form 4 does not show an open-market sale. Instead, 6,762 shares were withheld by MiMedx to satisfy tax withholding requirements on restricted stock vesting, which is a standard, non-discretionary compensation-related event.

How many MiMedx (MDXG) shares does the CCO hold after this tax withholding?

Following the tax withholding, Chief Commercial Officer Kimberly Maersk-Moller directly owned 329,450 MiMedx common shares. This figure reflects her position after 6,762 shares were withheld to cover taxes on vested restricted stock.

What transaction code is used in the MiMedx (MDXG) Form 4 and what does it mean?

The Form 4 uses transaction code “F,” indicating shares were disposed of to pay taxes or exercise costs. Here, it reflects 6,762 MiMedx shares withheld by the company to meet tax obligations from restricted stock vesting.